Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Vaccine ; 36(45): 6752-6760, 2018 10 29.
Artigo em Inglês | MEDLINE | ID: mdl-30268733

RESUMO

Virus-like particles (VLPs) have become a hot topic in modern vaccine research because of its safety, facile production, and immune properties. To further enhance the immune effect of VLPs, we synthesized and used gold-star nanoparticles (AuSNs) as adjuvant for vaccine. Foot-and-mouth disease (FMD) VLPs as target antigen were combined with AuSNs. The FMD VLPs-AuSNs complex was characterized through sodium dodecyl sulfate-polyacrylamide gel electrophoresis, Western blot, ultraviolet light absorption, and morphological measurement analyses. Result indicated that the FMD VLPs-AuSNs complex is non-toxic in different cell lines. AuSNs can effectively promote the entry of FMD VLPs into cells and improve macrophages activation when combined with FMD VLPs compared with FMD VLPs alone. Further animal vaccination and challenge tests revealed that the specific immune response and protection rate of AuSNs adjuvant group is higher than that of conventional mineral oil (ISA206) adjuvant group. AuSNs can effectively improve the immune protection effects of FMD VLPs vaccines, and exhibit potential as a new adjuvant for other vaccines.


Assuntos
Vírus da Febre Aftosa/imunologia , Febre Aftosa/imunologia , Febre Aftosa/prevenção & controle , Vacinas de Partículas Semelhantes a Vírus/imunologia , Adjuvantes Imunológicos/uso terapêutico , Animais , Anticorpos Neutralizantes/metabolismo , Feminino , Vírus da Febre Aftosa/patogenicidade , Cobaias , Camundongos , Testes de Neutralização , Células RAW 264.7 , Linfócitos T/metabolismo , Vacinação/métodos , Vacinas de Partículas Semelhantes a Vírus/uso terapêutico
2.
Pak J Pharm Sci ; 30(6): 2165-2172, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-29175786

RESUMO

Cytotoxic and antiviral activity of aqueous leaves extracts of three plants: Azadirachta indica, Moringa oleifera and Morus alba against Foot and Mouth disease virus (FMDV) were determined using MTT assay (3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide). Eight different concentrations of each plant were evaluated. Cytotoxic and antiviral activity of each extract was evaluated as cell survival percentage and results were expressed as Means ± S.D. From the tested plant extracts, Azadirachta indica & Moringa oleifera exhibited cytotoxicity at 200 & 100 µ/ml respectively. In case of antiviral assay, Moringa oleifera showed potent antiviral activity (p<0.05) while Azadirachta indica showed significant antiviral activity in the range of 12.5-50 µ/ml & 50-100 µ/ml respectively. In contrast no anti-FMDV activity in the present study was observed with Morus alba, although all the tested concentrations were found to be safe.


Assuntos
Agricultura , Antivirais/farmacologia , Azadirachta/química , Vírus da Febre Aftosa/efeitos dos fármacos , Febre Aftosa/tratamento farmacológico , Moringa oleifera/química , Extratos Vegetais/farmacologia , Folhas de Planta/química , Drogas Veterinárias/farmacologia , Animais , Antivirais/isolamento & purificação , Antivirais/toxicidade , Azadirachta/toxicidade , Linhagem Celular , Cricetinae , Relação Dose-Resposta a Droga , Fazendas , Febre Aftosa/diagnóstico , Febre Aftosa/virologia , Vírus da Febre Aftosa/patogenicidade , Moringa oleifera/toxicidade , Extratos Vegetais/isolamento & purificação , Extratos Vegetais/toxicidade , Folhas de Planta/toxicidade , Drogas Veterinárias/isolamento & purificação , Drogas Veterinárias/toxicidade
3.
Intervirology ; 48(4): 207-12, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15920343

RESUMO

The Isatis indigotica extract is widely used in clinical practice for the treatment of influenza, epidemic hepatitis, epidemic encephalitis B etc. The goal of this study was to investigate whether coinjection of the Isatis indigotica extract with foot-and-mouth disease virus (FMDV) DNA vaccine could increase the protective immune response. Mice were vaccinated twice with either FMDV DNA vaccine plus the Isatis indigotica extract or DNA vaccine alone. Compared with the group of DNA vaccine alone, in the group that received DNA vaccine plus the Isatis indigotica extract was observed a significant increase in not only FMDV-specific antibody response but also T cell proliferation assay. All swine immunized with either FMDV DNA vaccine plus the Isatis indigotica extract or DNA vaccine alone were partially protected from FMDV challenge, but the signs of DNA vaccine plus the Isatis indigotica extract group were less severe than that of DNA vaccine alone. Coinjection of the Isatis indigotica extract with DNA vaccine has adjuvant effect on the immune response against viral pathogens and its application provides an effective strategy to improve the efficacy of DNA vaccines.


Assuntos
Adjuvantes Imunológicos/administração & dosagem , Febre Aftosa/imunologia , Isatis/imunologia , Extratos Vegetais/imunologia , Vacinas de DNA/imunologia , Vacinas Virais/imunologia , Animais , Anticorpos Antivirais/sangue , Linhagem Celular , Febre Aftosa/prevenção & controle , Vírus da Febre Aftosa/imunologia , Vírus da Febre Aftosa/patogenicidade , Humanos , Isatis/química , Ativação Linfocitária , Camundongos , Camundongos Endogâmicos BALB C , Extratos Vegetais/administração & dosagem , Suínos , Doenças dos Suínos/imunologia , Doenças dos Suínos/prevenção & controle , Doenças dos Suínos/virologia , Linfócitos T/imunologia , Vacinação/veterinária , Vacinas de DNA/administração & dosagem , Vacinas Virais/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA